The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 341.00
Bid: 325.00
Ask: 346.00
Change: 1.00 (0.29%)
Spread: 21.00 (6.462%)
Open: 340.00
High: 341.00
Low: 327.00
Prev. Close: 340.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: City of London Investment Group (CLIG): Handling challenging markets well

22 Apr 2020 15:05

Hardman & Co Research Hardman & Co Research: City of London Investment Group (CLIG): Handling challenging markets well 22-Apr-2020 / 15:05 GMT/BST


Hardman & Co Research: Handling challenging markets well

City of London has announced a trading update for 3Q'20. Market conditions have been challenging for fund managers. With a largely institutional investor base, there has been a mixture of subscriptions and withdrawals, with net withdrawals in the quarter of $35m. Falling markets weighed more heavily on FUM and, at the end of March, total FUM were $4.40bn, down from $6.01bn three months earlier. We do note that markets have recovered somewhat so far in April, suggesting current FUM will have clawed some of that back. No decision has been taken on the dividend, but near-term increases look unlikely

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/handling-challenging-markets-well/

If you are interested in meeting the company, you can register your interest by clicking on the above link.

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Brian Moretta+44 20 7194 7622

 

bm@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1027663 22-Apr-2020 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
31st Dec 201512:35 pmRNSPrice Monitoring Extension
15th Dec 201510:41 amRNSShare Buy Back
30th Nov 20152:27 pmRNSHolding(s) in Company
10th Nov 20154:31 pmRNSDirector/PDMR Shareholding
21st Oct 20154:52 pmRNSPDMR Share Holding/Share Buy Back
20th Oct 20154:05 pmRNSHardman & Co issues research report
19th Oct 20154:36 pmRNSResult of AGM
19th Oct 20157:00 amRNSAGM Trading Update
8th Oct 20156:01 pmRNSHardman & Co issues research
8th Oct 20157:00 amRNSInterim Management Statement
15th Sep 201511:18 amRNSHardman & Co issues research report
14th Sep 20157:00 amRNSFinal Results
1st Sep 20154:35 pmRNSPrice Monitoring Extension
28th Aug 201512:04 pmRNSText of letter to icapital.biz Berhad
25th Aug 20157:00 amRNSDividend Timetable
21st Aug 20157:00 amRNSBoard Changes
16th Jul 20153:08 pmRNSHardman & Co issues research report
15th Jul 20157:00 amRNSTrading Update
2nd Jul 20153:56 pmRNSBlocklisting Interim Review
19th Jun 20154:07 pmRNSDirector/PDMR Shareholding
17th Apr 20153:03 pmRNSDirector/PDMR Shareholding
8th Apr 20157:00 amRNSInterim Management Statement
18th Feb 20154:58 pmRNSDirector/PDMR Shareholding
11th Feb 20157:00 amRNSInterim Results
6th Jan 20157:00 amRNSFUNDS UNDER MANAGEMENT AT 31/12/14 TRADING UPDATE
2nd Jan 20157:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
19th Dec 201410:56 amRNSHolding(s) in Company
12th Dec 20149:15 amRNSShare Buyback and Total Voting Rights
11th Dec 20149:18 amRNSShare Buyback and Total Voting Rights
13th Nov 20143:43 pmRNSShare Buyback and Total Voting Rights
3rd Nov 20148:54 amRNSShare Buy Back and Total Voting Rights
22nd Oct 20145:17 pmRNSResult of AGM
22nd Oct 20147:00 amRNSInterim Management Statement
8th Oct 20149:14 amRNSHolding(s) in Company
15th Sep 20147:00 amRNSFinal Results
15th Jul 20147:00 amRNSTrading Update
1st Jul 20147:00 amRNSBlocklisting Interim Review
22nd May 20144:35 pmRNSPrice Monitoring Extension
25th Apr 20145:06 pmRNSHolding(s) in Company
5th Mar 201411:41 amRNSDirector/PDMR Shareholding
4th Mar 20147:00 amRNSQuarterly Funds under Management ("FuM") Update
20th Jan 20147:00 amRNSHalf Yearly Results
2nd Jan 20142:13 pmRNSBlocklisting Interim Review
2nd Dec 20137:00 amRNSTrading Update
8th Oct 20134:10 pmRNSResult of AGM
7th Oct 20137:00 amRNSInterim Management Statement
13th Sep 201310:02 amRNSHolding(s) in Company
12th Sep 201310:48 amRNSHolding(s) in Company
9th Sep 20137:00 amRNSFinal Results
23rd Jul 201310:06 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.